Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7191052
Reference Type
Journal Article
Title
Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
Author(s)
Wang, D; Yang, Y; Lei, Y; Tzvetkov, NT; Liu, X; Yeung, AWK; Xu, S; Atanasov, AG; ,
Year
2019
Is Peer Reviewed?
1
Journal
Pharmacological Reviews
ISSN:
0031-6997
EISSN:
1521-0081
Publisher
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
Location
BETHESDA
Page Numbers
596-670
Language
English
PMID
31554644
DOI
10.1124/pr.118.017178
Web of Science Id
WOS:000500540700007
Abstract
Foam cell formation and further accumulation in the subendothelial space of the vascular wall is a hallmark of atherosclerotic lesions. Targeting foam cell formation in the atherosclerotic lesions can be a promising approach to treat and prevent atherosclerosis. The formation of foam cells is determined by the balanced effects of three major interrelated biologic processes, including lipid uptake, cholesterol esterification, and cholesterol efflux. Natural products are a promising source for new lead structures. Multiple natural products and pharmaceutical agents can inhibit foam cell formation and thus exhibit antiatherosclerotic capacity by suppressing lipid uptake, cholesterol esterification, and/or promoting cholesterol ester hydrolysis and cholesterol efflux. This review summarizes recent findings on these three biologic processes and natural products with demonstrated potential to target such processes. Discussed also are potential future directions for studying the mechanisms of foam cell formation and the development of foam cell-targeted therapeutic strategies.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity